Date Hour Room Track
04th December,2018 2:30-4:00 pm Track 2

What are the latest group actions to have been jointly taken by the industry, academic institutions, equity investors, and governmental bodies that take academic-origin assets as early as possible and inject the proper amount of money into them, in order to get the project licensed at the right moment and at the safest possible stage?

Speakers
Steven J. Klein - IRICoR - Institute for Research in Immunology and Cancer-Commercialization of Research
Michael L. Salgaller - National Institutes of Health (NIH) | National Cancer Institute (NCI) | Technology Transfer Center

Continue your tour